Home > Riviste > Italian Journal of Dermatology and Venereology > Fascicoli precedenti > Articles online first > Giornale Italiano di Dermatologia e Venereologia 2020 Oct 09

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Giornale Italiano di Dermatologia e Venereologia 2020 Oct 09

DOI: 10.23736/S0392-0488.20.06619-5

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Atypical pemphigus: autoimmunity against desmocollins and other non-desmoglein autoantigens

Bruno GUALTIERI 1, Angelo V. MARZANO 2, 3, Sergei GRANDO 4, 5, 6

1 Department of Dermatology, Ospedale “Santi Giovanni e Paolo”, Venice, Italy; 2 Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; 3 Department of Physiopathology and Transplantation, Università degli Studi di Milano, Milan, Italy: 4 Department of Dermatology, University of California, Irvine, CA, USA; 5 Department of Biological Chemistry, University of California, Irvine, CA, USA; 6 Institute for Immunology, University of California, Irvine, CA, USA


PDF


In this review, we recap current knowledge about non-desmoglein autoantigens in atypical forms of autoimmune pemphigus. More than 50 keratinocyte proteins, including adhesion molecules, receptors and enzymes as well as mitochondrial proteins can be targeted, leading to alterations in numerous intracellular signaling pathways. Patients with pemphigus herpetiformis feature various combinations of antibodies to desmogleins 1 and 3 and desmocollins 1-3. Pemphigus vulgaris patients who do not have antibodies to desmogleins develop typical clinical and histological features of pemphigus. Experimental results revealed synergy of different autoantibodies. Alterations of the keratinocyte adhesive function caused by a single antibody alone are reversible due to self-repair. Since composition of the pool of the most common pathogenic antibodies appears to be similar among pemphigus patients with or without antidesmoglein antibodies, the atypical pemphigus represents a unique model for elucidation of the molecular mechanisms of autoimmunity against non-desmoglein antigens. Further studies of the immunopathology of atypical pemphigus should shed new lights on the pathophysiology of conventional variants of autoimmune pemphigus.


KEY WORDS: Pemphigus vulgaris; Pemphigus herpetiformis; Non-desmoglein antibodies; M3 muscarinic receptor; Secretory pathway Ca2+/Mn2+-ATPase isoform 1; Desmoglein; Desmocollin; Autoantibody

inizio pagina